Azurity Pharmaceuticals is proud to support updates to the American Academy of Sleep Medicine’s clinical practice guidelines for Restless Legs Syndrome (RLS). A condition affecting millions, RLS is a sleep-related movement disorder that prompts an irresistible urge to move one or both legs – and sometimes arms – accompanied by an uncomfortable feeling. The new guidelines aim to improve diagnosis, treatment, and management strategies for this debilitating condition. For more information on RLS and its management, visit RLS.org or consult with your healthcare provider about available treatment options from Azurity Pharmaceuticals.
Source: https://www.abcactionnews.com/morning-blend/updated-practice-guidelines-for-treating-restless-legs-syndrome-rls